Accelerated Amyloid Deposition in the Brains of Transgenic Mice Coexpressing Mutant Presenilin 1 and Amyloid Precursor Proteins

Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

McKhann, G., Drachman, D., Folstein, M., Katzman, R., Price, D., & Stadlan, E. M. (1984) · Neurology · doi:10.1212/wnl.34.7.939 · Cited by 27,915

Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease

Goate, A., Chartier-Harlin, M.-C., Mullan, M., Brown, J., Crawford, F., Fidani, L., Giuffra, L., Haynes, A., Irving, N., James, L., et al. (1991) · Nature · doi:10.1038/349704a0 · Cited by 4,659

Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice

Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210

Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

Sherrington, R., Rogaev, E. I., Liang, Y., Rogaeva, E. A., Levesque, G., Ikeda, M., Chi, H., Lin, C., Li, G., Holman, K., et al. (1995) · Nature · doi:10.1038/375754a0 · Cited by 4,051

Secreted amyloid β–protein similar to that in the senile plaques of Alzheimer's disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer's disease

Scheuner, D., Eckman, C., Jensen, M., Song, X., Citron, M., Suzuki, N., Bird, T. D., Hardy, J., Hutton, M., Kukull, W., et al. (1996) · Nature Medicine · doi:10.1038/nm0896-864 · Cited by 2,599

Candidate gene for the chromosome 1 familial Alzheimer’s disease locus

Levy-Lahad, E., Wasco, W., Poorkaj, P., Romano, D. M., Oshima, J., Pettingell, W. H., Yu, C.-E., Jondro, P. D., Schmidt, S. D., Wang, K., et al. (1995) · Science · doi:10.1126/science.7638622 · Cited by 2,577

Alzheimer-type neuropathology in transgenic mice overexpressing V717F β-amyloid precursor protein

Games, D., Adams, D., Alessandrini, R., Barbour, R., Borthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995) · Nature · doi:10.1038/373523a0 · Cited by 2,516

Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

Rogaev, E. I., Sherrington, R., Rogaeva, E. A., Levesque, G., Ikeda, M., Liang, Y., Chi, H., Lin, C., Holman, K., Tsuda, T., et al. (1995) · Nature · doi:10.1038/376775a0 · Cited by 2,052

The carboxy terminus of the .beta. amyloid protein is critical for the seeding of amyloid formation: Implications for the pathogenesis of Alzheimer's disease

Jarrett, J. T., Berger, E. P., & Lansbury, P. T. (1993) · Biochemistry · doi:10.1021/bi00069a001 · Cited by 2,022

Discovery and characterization of a mammalian amyloid disaggregation activity

Murray, A. N., Solomon, J. P., Wang, Y., Balch, W. E., & Kelly, J. W. (2010) · Protein Science · doi:10.1002/pro.363 · Cited by 31

Comprehensive analysis of PM20D1 QTL in Alzheimer’s disease

Sanchez-Mut, J. V., Glauser, L., Monk, D., & Gräff, J. (2020) · Clinical Epigenetics · doi:10.1186/s13148-020-0814-y · Cited by 31

Cognitive and histological disturbances after chlorpyrifos exposure and chronic Aβ(1–42) infusions in Wistar rats

Ruiz-Muñoz, A. M., Nieto-Escámez, F. A., Aznar, S., Colomina, M. T., & Sánchez-Santed, F. (2011) · NeuroToxicology · doi:10.1016/j.neuro.2011.05.014 · Cited by 31

Animal Models of Neurological Disease

Shah, A., Garzón-Muvdi, T., Mahajan, R. K., Duenas, V. J., & Quiñones-Hinojosa, A. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-5819-8_3 · Cited by 31

Parallel increase in p70 kinase activation and tau phosphorylation (S262) with Aβ overproduction

Zhou, X., Tanila, H., & Pei, J.-J. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.11.078 · Cited by 31

SHIRPA as a neurological screening battery in mice

Lalonde, R., Filali, M., & Strazielle, C. (2021) · Current Protocols · doi:10.1002/cpz1.135 · Cited by 30

High-Fat-Diet-Induced Weight Gain Ameliorates Bone Loss without Exacerbating AβPP Processing and Cognition in Female APP/PS1 Mice

Peng, Y., Liu, J., Tang, Y., Liu, J., Han, T., Han, S., Li, H., Hou, C., Liu, J., & Long, J. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00225 · Cited by 30

BACE2 variant identified from HSCR patient causes AD-like phenotypes in hPSC-derived brain organoids

Luo, J., Zou, H., Guo, Y., Huang, K., Ngan, E., & Li, P. (2022) · Cell Death Discovery · doi:10.1038/s41420-022-00845-5 · Cited by 30

Animal models of Alzheimer’s disease: preclinical insights and challenges

Xu, Q., Yang, W., Zhong, M., Lin, Z., Gray, N. E., & Xian, Y. (2023) · Acta Materia Medica · doi:10.15212/amm-2023-0001 · Cited by 30

Increased Expression of PS1 Is Sufficient to Elevate the Level and Activity of γ-Secretase In Vivo

Li, T., Li, Y., Ahn, K., Price, D. L., Sisodia, S. S., & Wong, P. C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028179 · Cited by 30

Nogo Receptor Interacts with Brain APP and Aβ to Reduce Pathologic Changes in Alzheimers Transgenic Mice

Park, J. H., & Strittmatter, S. M. (2007) · Current Alzheimer Research · doi:10.2174/156720507783018235 · Cited by 30

P75 neurotrophin receptor regulates expression of neural cell adhesion molecule 1

Korade, Ž., Yan, C., Portugal, C. F., Kim, T.-W., Saragovi, H. U., Sisodia, S. S., Mirnics, K., & Schor, N. F. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.06.004 · Cited by 30

Merger of Laser Capture Microdissection and Mass Spectrometry: A Window into the Amyloid Plaque Proteome

Gozal, Y. M., Cheng, D., Duong, D. M., Lah, J. J., Levey, A. I., & Peng, J. (2006) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(06)12006-6 · Cited by 30

Presenilin-1 Protects against Neuronal Apoptosis Caused by Its Interacting Protein PAG

Zhou, Y., Zhang, W., Easton, R., Ray, J. W., Lampe, P. A., Jiang, Z., Brunkan, A. L., Goate, A., Johnson, E. M., & Wu, J. Y. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0472 · Cited by 30

Akt activation ameliorates deficits in hippocampal-dependent memory and activity-dependent synaptic protein synthesis in an Alzheimer’s disease mouse model

Kommaddi, R. P., Gowaikar, R., Haseena, P. A., Diwakar, L., Singh, K. P., & Mondal, A. (2024) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2023.105619 · Cited by 29

Human Umbilical Cord Blood-Derived Monocytes Improve Cognitive Deficits and Reduce Amyloid-β Pathology in PSAPP Mice

Darlington, D., Li, S., Hou, H., Habib, A., Tian, J., Gao, Y., Ehrhart, J. C., Sanberg, P. R., Sawmiller, D. R., Giunta, B. N., et al. (2015) · Cell Transplantation · doi:10.3727/096368915x688894 · Cited by 29

Does Alzheimer's disease exist in all primates? Alzheimer pathology in non-human primates and its pathophysiological implications (I)

Tolédano, A., Álvarez, M. I., López-Rodríguez, A. B., Toledano‐Díaz, A., & Fernández, C. I. (2012) · Neurología (English Edition) · doi:10.1016/j.nrleng.2012.07.002 · Cited by 29

Suppressed Retinal Degeneration in Aged Wild Type and APPswe/PS1ΔE9 Mice by Bone Marrow Transplantation

Yang, Y. J., Shiao, C., Hemingway, J. F., Jorstad, N. L., Shalloway, B. R., Chang, R. C., & Keene, C. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064246 · Cited by 29

Fus1 KO Mouse As a Model of Oxidative Stress-Mediated Sporadic Alzheimer's Disease: Circadian Disruption and Long-Term Spatial and Olfactory Memory Impairments

Coronas‐Samano, G., Baker, K. L., Tan, W. J. T., Ivanova, A. V., & Verhagen, J. V. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00268 · Cited by 29

Transgenic Mouse Models of Alzheimer's Disease and Amyotrophic Lateral Sclerosis

Borchelt, D., Wong, P. C., Sisodia, S. S., & Price, D. L. (1998) · Brain Pathology · doi:10.1111/j.1750-3639.1998.tb00198.x · Cited by 29

Transgenic Animals in Alzheimer's Disease Research

Sturchler, C., & Sommer, B. (1999) · Reviews in the Neurosciences · doi:10.1515/revneuro.1999.10.1.15 · Cited by 29

Brain Lipid Dynamics in Amyloid Precursor Protein/Presenilin 1 Mouse Model of Early Alzheimer’s Disease by Desorption Electrospray Ionization and Matrix Assisted Laser Desorption Ionization–Mass Spectrometry Imaging Techniques

Xue-ju, Z., Wu, C., & Tan, W. (2021) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c01050 · Cited by 28

Astrocytes display ultrastructural alterations and heterogeneity in the hippocampus of aged APP-PS1 mice and human post-mortem brain samples

St‐Pierre, M., Carrier, M., Ibáñez, F. G., Khakpour, M., Wallman, M., Parent, M., & Tremblay, M. (2023) · Journal of Neuroinflammation · doi:10.1186/s12974-023-02752-7 · Cited by 28

Fleshing out the amyloid cascade hypothesis: the molecular biology of Alzheimer's disease

Lovestone, S. (2000) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2000.2.2/slovestone · Cited by 28

High sensitivity to carcinogens in the brain of a mouse model of Alzheimer's disease

Serrano, J., Fernández, A. P., Martínez‐Murillo, R., & Martı́nez, A. (2010) · Oncogene · doi:10.1038/onc.2009.503 · Cited by 28

Correlative Light and Electron Microscopy to Study Microglial Interactions with β-Amyloid Plaques

Bisht, K., Hajj, H. E., Savage, J. C., Sanchez, M. G., & Tremblay, M. (2016) · Journal of Visualized Experiments · doi:10.3791/54060 · Cited by 28

Effects of altered RTN3 expression on BACE1 activity and Alzheimer’s neuritic plaques

Sharoar, M. G., & Yan, R. (2016) · Reviews in the Neurosciences · doi:10.1515/revneuro-2016-0054 · Cited by 28

Tracking the decline in cerebral glucose metabolism in persons and laboratory animals at genetic risk for Alzheimer's disease

Reiman, E. M., Caselli, R. J., Alexander, G. E., & Chen, K. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(01)00006-8 · Cited by 28

Hepatic LRP-1 plays an important role in amyloidosis in Alzheimer's disease mice: Potential role in chronic heavy alcohol feeding

Chandrashekar, D. V., Roules, G. C., Jagadeesan, N., Panchal, U. R., Oyegbesan, A., Imiruaye, O. E., Zhang, H., Garcia, J., Kaur, K., Win, S., et al. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106570 · Cited by 27

A systems biology investigation of neurodegenerative dementia reveals a pivotal role of autophagy

Caberlotto, L., & Nguyen, T.-P. (2014) · BMC Systems Biology · doi:10.1186/1752-0509-8-65 · Cited by 27

Neuro-Immuno-Gene- and Genome-Editing-Therapy for Alzheimer’s Disease: Are We There Yet?

Raikwar, S. P., Thangavel, R., Dubova, I., Ahmed, M. E., Selvakumar, G. P., Kempuraj, D., Zaheer, S. A., Iyer, S. S., & Zaheer, A. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-180422 · Cited by 27

Deposition of amyloid fibrils promotes cell-surface accumulation of amyloid β precursor protein

Heredia, L., Lin, R., Vigo, F. S., Kedikian, G., Busciglio, J. A., & Lorenzo, A. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.04.015 · Cited by 27

Transgenic mouse models of Alzheimer's disease: phenotype and mechanisms of pathogenesis

Duff, K. (2001) · Biochemical Society Symposia · doi:10.1042/bss0670195 · Cited by 27

Developmental Expression of Wild-Type and Mutant Presenilin-1 in Hippocampal Neurons from Transgenic Mice: Evidence for Novel Species-Specific Properties of Human Presenilin-1

Lévesque, L., Annaert, W. G., Craessaerts, K., Mathews, P. M., Seeger, M., Nixon, R. A., Leuven, F. V., Gandy, S., Westaway, D. A., George‐Hyslop, P. S., et al. (1999) · Molecular Medicine · doi:10.1007/bf03401981 · Cited by 27

Role of Species-Specific Primary Structure Differences in Aβ42 Assembly and Neurotoxicity

Roychaudhuri, R., Zheng, X., Lomakin, A., Maiti, P., Condron, M. M., Benedek, G. B., Bitan, G., Bowers, M. T., & Teplow, D. B. (2015) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.5b00180 · Cited by 26

Intravenous ascorbate improves spatial memory in middle-aged APP/PSEN1 and wild type mice

Kennard, J. A., & Harrison, F. E. (2014) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.01.044 · Cited by 26

Elevation of plasma β-amyloid level by glucose loading in Alzheimer mouse models

Takeda, S., Sato, N., Uchio‐Yamada, K., Sawada, K., Kunieda, T., Takeuchi, D., Kurinami, H., Shinohara, M., Rakugi, H., & Morishita, R. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.05.037 · Cited by 26

Altered levels and distribution of IGF-II/M6P receptor and lysosomal enzymes in mutant APP and APP+PS1 transgenic mouse brains

Amritraj, A., Hawkes, C. A., Phinney, A. L., Mount, H. T. J., Scott, C. D., Westaway, D. A., & Kar, S. (2007) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.05.004 · Cited by 26

A fingerprint of amyloid plaques in a bitransgenic animal model of Alzheimer's disease obtained by statistical unmixing analysis of hyperspectral Raman data

Fonseca, E. A., Lafetá, L., Cunha, R. S., de Miranda, H. L. S., Campos, J. L. E., de Medeiros, H. G., Romano‐Silva, M. A., Silva, R. A., Barbosa, A. S., Vieira, R. P., et al. (2019) · The Analyst · doi:10.1039/c9an01631g · Cited by 26

Brain neprilysin activity and susceptibility to transgene-induced Alzheimer amyloidosis

Carter, T. L., Pedrini, S., Ghiso, J. A., Ehrlich, M. E., & Gandy, S. (2005) · Neuroscience Letters · doi:10.1016/j.neulet.2005.09.022 · Cited by 26

A Novel Mouse Model of Alzheimer's Disease with Chronic Estrogen Deficiency Leads to Glial Cell Activation and Hypertrophy

Prat, A., Behrendt, M., Marcinkiewicz, E., Boridy, S., Sairam, R., Seidah, N. G., & Maysinger, D. (2011) · Journal of Aging Research · doi:10.4061/2011/251517 · Cited by 26

Fenofibrate reduces amyloidogenic processing of APP in APP/PS1 transgenic mice via PPAR‐α/PI3‐K pathway

Zhang, H., Gao, Y., Qiao, P., Zhao, F., & Yan, Y. (2014) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2014.10.004 · Cited by 26

Brain prolyl oligopeptidase activity is associated with neuronal damage rather than β-amyloid accumulation

Laitinen, K. S. M., van Groen, T., Tanila, H., Venäläinen, J. I., Männistö, P. T., & Alafuzoff, I. I. (2001) · Neuroreport · doi:10.1097/00001756-200110290-00032 · Cited by 26

Amyloid-β-protein isoforms in brain of subjects with PS1-linked, βAPP-linked and sporadic Alzheimer disease

Tamaoka, A., Fraser, P. E., Ishii, K., Sahara, N., Ozawa, K., Ikeda, M., Saunders, A. M., Komatsuzaki, Y., Sherrington, R., Lévesque, G., et al. (1998) · Molecular Brain Research · doi:10.1016/s0169-328x(98)00044-8 · Cited by 26

Amyloid-Beta Immunization in Alzheimer's Disease Transgenic Mouse Models and Wildtype Mice

Lemere, C. A., Spooner, E. T., Leverone, J. F., Mori, C., Iglesias, M., Bloom, J. K., & Seabrook, T. J. (2003) · Neurochemical Research · doi:10.1023/a:1023203122036 · Cited by 26

Lack of human-like extracellular sortilin neuropathology in transgenic Alzheimer’s disease model mice and macaques

Zhou, F., Jiang, J., Griffith, C. M., Patrylo, P. R., Cai, H., Chu, Y., & Yan, X. (2018) · Alzheimer s Research & Therapy · doi:10.1186/s13195-018-0370-2 · Cited by 25

Simvastatin Treatment Preserves Synaptic Plasticity in AβPPswe/PS1dE9 Mice

Métais, C., Brennan, K., Mably, A. J., Scott, M., Walsh, D. M., & Herron, C. E. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-130257 · Cited by 25

Cholinergic axon length reduced by 300 meters in the brain of an Alzheimer mouse model

Nikolajsen, G. N., Jensen, M. S., & West, M. J. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.05.006 · Cited by 25

A pH-dependent conformational transition of Aβ peptide and physicochemical properties of the conformers in the glial cell

Matsunaga, Y., SAITO, N., Fujii, A., Yokotani, J., Takakura, T., NISHIMURA, T., ESAKI, H., & Yamada, T. (2002) · Biochemical Journal · doi:10.1042/0264-6021:3610547 · Cited by 25

Neuroprotective effect of Coenzyme Q10 on ischemic hemisphere in aged mice with mutations in the amyloid precursor protein

Li, G., Zou, L., Jack, C. R., Yang, Y., & Yang, E. S. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2006.05.005 · Cited by 25

Aging Is Not Associated with Proteasome Impairment in UPS Reporter Mice

Cook, C. N., Gass, J. M., Dunmore, J., Tong, J., Taylor, J. P., Eriksen, J. L., McGowan, E. M., Lewis, J. M., Johnston, J. A., & Petrucelli, L. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005888 · Cited by 25

Progesterone reduces depression-like behavior in a murine model of Alzheimer’s Disease

Frye, C. A., & Walf, A. A. (2009) · AGE · doi:10.1007/s11357-009-9091-6 · Cited by 25

Aberrant induction of Par-4 is involved in apoptosis of hippocampal neurons in presenilin-1 M146V mutant knock-in mice

Xie, J., Chang, X., Zhang, X., & Guo, Q. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02803-7 · Cited by 25

Distinguishable effects of Presenilin-1 and APP717 mutations on amyloid plaque deposition

Ishii, K., Lippa, C. F., Tomiyama, T., Miyatake, F., Ozawa, K., Tamaoka, A., Hasegawa, T., Fraser, P. E., Shoji, S., Nee, L. E., et al. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00216-0 · Cited by 25

Monitoring protein aggregation and toxicity in Alzheimer's disease mouse models using in vivo imaging

Spires-Jones, T. L., Calignon, A. D., Meyer-Luehmann, M., Bacskai, B. J., & Hyman, B. T. (2011) · Methods · doi:10.1016/j.ymeth.2010.12.009 · Cited by 24

Nonlinear and vibrational microscopy for label-free characterization of amyloid-β plaques in Alzheimer's disease model

Cunha, R. S., Lafetá, L., Fonseca, E. A., Barbosa, A. S., Romano‐Silva, M. A., Vieira, R. P., Jório, A., & Malard, L. M. (2021) · The Analyst · doi:10.1039/d1an00074h · Cited by 24

Age-Dependent Hippocampal Proteomics in the APP/PS1 Alzheimer Mouse Model: A Comparative Analysis with Classical SWATH/DIA and directDIA Approaches

van der Spek, S. J. F., Gonzalez‐Lozano, M. A., Koopmans, F., Miedema, S. S. M., Paliukhovich, I., Smit, A. B., & Li, K. W. (2021) · Cells · doi:10.3390/cells10071588 · Cited by 24

Does Nitric Oxide Synthase Contribute to the Pathogenesis of Alzheimer's Disease?

Lahiri, D. K., Chen, D., GE, Y. ‐., Farlow, M. R., Kotwal, G. J., Kanthasamy, A. G., Ingram, D. K., & Greig, N. H. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.117 · Cited by 24

Decreased Aβ secretion by cells expressing familial Alzheimer's disease-linked mutant presenilin 1

Shimojo, M., Sahara, N., Murayama, M., Ichinose, H., & Takashima, A. (2007) · Neuroscience Research · doi:10.1016/j.neures.2006.12.005 · Cited by 24

Vaccination Strategies for Alzheimer???s Disease

Woodhouse, A., Dickson, T. C., & Vickers, J. C. (2007) · Drugs & Aging · doi:10.2165/00002512-200724020-00003 · Cited by 24

Ovariectomy of young mutant amyloid precursor protein transgenic mice leads to increased mortality

Levin-Allerhand, J. A., & Smith, J. D. (2002) · Journal of Molecular Neuroscience · doi:10.1007/s12031-002-0027-1 · Cited by 24

Aβ levels in serum, CSF and brain, and cognitive deficits in APP + PS1 transgenic mice

Liu, L., Tapiola, T., Herukka, S., Heikkilä, M., & Tanila, H. (2003) · Neuroreport · doi:10.1097/00001756-200301200-00030 · Cited by 24

Molecular signatures of neurodegeneration in the cortex of PS1/PS2 double knockout mice

Mirnics, K., Norstrom, E. M., Garbett, K., Choi, S., Zhang, X., Ebert, P., & Sisodia, S. S. (2008) · Molecular Neurodegeneration · doi:10.1186/1750-1326-3-14 · Cited by 23

Ascorbate deficiency decreases dopamine release in gulo–/– and APP/PSEN1 mice

Consoli, D. C., Brady, L. J., Bowman, A. B., Calipari, E. S., & Harrison, F. E. (2020) · Journal of Neurochemistry · doi:10.1111/jnc.15151 · Cited by 23

A New Approach to Model Sporadic Alzheimer’s Disease by Intracerebroventricular Streptozotocin Injection in APP/PS1 Mice

Kelliny, S., Lin, L., Deng, I. B., Xiong, J., Zhou, F. H., Al‐Hawwas, M., Bobrovskaya, L., & Zhou, X. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02338-5 · Cited by 23

In vitro and in vivo models for anti-amyloidosis nanomedicines

Käkinen, A., Javed, I., Davis, T. P., & Ke, P. C. (2021) · Nanoscale Horizons · doi:10.1039/d0nh00548g · Cited by 23

An APP ectodomain mutation outside of the Aβ domain promotes Aβ production in vitro and deposition in vivo

Zhang, X., Zhang, C. M., Prokopenko, D., Liang, Y., Zhen, S. Y., Weigle, I. Q., Han, W., Aryal, M., Tanzi, R. E., & Sisodia, S. S. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20210313 · Cited by 23

Zinc Enhances Synthesis of Presenilin 1 in Mouse Primary Cortical Culture

Park, I.-H., Jung, M. W., Mori, H., & Mook‐Jung, I. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.5243 · Cited by 23

Elevated levels of Aβ1–40 and Aβ1–42 do not alter the binding sites of nicotinic receptor subtypes in the brain of APPswe and PS1 double transgenic mice

Marutle, A., Unger, C., Hellström‐Lindahl, E., Wang, J., Puoliväli, J. T., Tanila, H., Nordberg, A. K., & Zhang, X. (2002) · Neuroscience Letters · doi:10.1016/s0304-3940(02)00546-3 · Cited by 23

Building a More Perfect Beast

Dickson, D. W. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63202-6 · Cited by 23

GENETICALLY MODIFIED MICE IN NEUROPHARMACOLOGY

Brusa, R. (1999) · Pharmacological Research · doi:10.1006/phrs.1998.0457 · Cited by 23

Neurotoxic APP C-terminal and β-amyloid domains colocalize in the nuclei of substantia nigra pars reticulata neurons undergoing delayed degeneration

DeGiorgio, L. A., DeGiorgio, N., Milner, T. A., Conti, B., & Volpe, B. T. (2000) · Brain Research · doi:10.1016/s0006-8993(00)02545-2 · Cited by 23

Cell competition from development to neurodegeneration

RODRIGUES, M. C., Couceiro, J., & Moreno, E. (2021) · Disease Models & Mechanisms · doi:10.1242/dmm.048926 · Cited by 22

Barriers to developing a valid rodent model of Alzheimer's disease: from behavioral analysis to etiological mechanisms

Gidyk, D. C., Deibel, S. H., Hong, N. S., & McDonald, R. J. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00245 · Cited by 22

Peripherally Applied Synthetic Tetrapeptides HAEE and RADD Slow Down the Development of Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice

Tsvetkov, P. O., Cheglakov, I. B., Ovsepyan, A. A., Mediannikov, O., Morozov, A. O., Telegin, G. B., & Kozin, S. A. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150031 · Cited by 22

Neuroendocrinology of Neurodegenerative Diseases

de Aguilar, J. G., René, F., Dupuis, L., & Loeffler, J. (2003) · Neuroendocrinology · doi:10.1159/000074445 · Cited by 22

Amyloid, memory and neurogenesis

Morgan, D. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.03.006 · Cited by 22

γ‐Secretase in microglia – implications for neurodegeneration and neuroinflammation

Walter, J., Kemmerling, N., Wunderlich, P., & Glebov, K. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14224 · Cited by 21

Switching On/Off Amyloid Plaque Formation in Transgenic Animal Models of Alzheimer’s Disease

Kozin, S. A., Kechko, O. I., Adzhubei, A. A., Makarov, A. А., & Mitkevich, V. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010072 · Cited by 21

Transcriptional Regulation of TMP21 by NFAT

Liu, S., Zhang, S., Bromley‐Brits, K., Cai, F., Zhou, W., Xia, K., Mittelholtz, J., & Song, W. (2011) · Molecular Neurodegeneration · doi:10.1186/1750-1326-6-21 · Cited by 21

Synapsin-caveolin-1 gene therapy preserves neuronal and synaptic morphology and prevents neurodegeneration in a mouse model of AD

Wang, S., Leem, J. S., Podvin, S., HOOK, V. Y. H., Kleschevnikov, N., Savchenko, P., Dhanani, M., Zhou, K., Kelly, I., Zhang, T., et al. (2021) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2021.03.021 · Cited by 21

Neuroprotection in early stages of Alzheimer’s disease is promoted by transthyretin angiogenic properties

Gião, T., Saavedra, J., Vieira, J. R., Pinto, M. T., Arsequell, G., & Cardoso, I. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00883-8 · Cited by 21

RTN/Nogo in forming Alzheimer's neuritic plaques

Prior, M., Shi, Q., Hu, X., He, W., Levey, A. I., & Yan, R. (2010) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.01.017 · Cited by 21

Accumulation of proteolytic fragments of mutant presenilin 1 and accelerated amyloid deposition are co-regulated in transgenic mice

Borchelt, D., Lee, M. K., Gonzales, V., Slunt, H. H., Ratovitski, T., Jenkins, N. A., Copeland, N. G., Price, D. L., & Sisodia, S. S. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00280-9 · Cited by 21

Novel aspects of accumulation dynamics and Aβ composition in transgenic models of AD

Lewis, H. D., Beher, D., Smith, D., Hewson, L., Cookson, N., Reynolds, D. S., Dawson, G. R., Jiang, M., der Ploeg, L. H. T. V., Qian, S., et al. (2004) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2003.12.009 · Cited by 21

Animal models and human tissue compared to better understand and treat the epilepsies

Milior, G., Morin‐Brureau, M., Pallud, J., Miles, R., & Huberfeld, G. (2023) · Epilepsia · doi:10.1111/epi.17552 · Cited by 20

Rodent Models of Alzheimer’s Disease: Past Misconceptions and Future Prospects

Collins, H. M., & Greenfield, S. A. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25116222 · Cited by 21

Transgenic Models of Alzheimer's Disease

Sugarman, M. C., Hinton, S. F., & LaFerla, F. M. (2001) · Humana Press eBooks · doi:10.1007/978-1-59259-006-3_2 · Cited by 20

Effect of Neocortical and Hippocampal Amyloid Deposition upon Galaninergic and Cholinergic Neurites in AβPPswe/PS1ΔE9 Mice

Kelley, C. M., Perez, S. E., Overk, C., Wynick, D., & Mufson, E. J. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-102097 · Cited by 20

Reduction in CHT1-mediated choline uptake in primary neurons from presenilin-1 M146V mutant knock-in mice

Payette, D. J., Xie, J., & Guo, Q. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.005 · Cited by 20

Intravenously Injected Amyloid-β Peptide With Isomerized Asp7 and Phosphorylated Ser8 Residues Inhibits Cerebral β-Amyloidosis in AβPP/PS1 Transgenic Mice Model of Alzheimer’s Disease

Kozin, S. A., Barykin, E. P., Telegin, G. B., Чернов, А. С., Adzhubei, A. A., Radko, S. P., Mitkevich, V. A., & Makarov, A. А. (2018) · Frontiers in Neuroscience · doi:10.3389/fnins.2018.00518 · Cited by 20

BACE1 and Mutated Presenilin-1 Differently Modulate Aβ40 and Aβ42 Levels and Cerebral Amyloidosis in APPDutch Transgenic Mice

Herzig, M. C., Paganetti, P., Staufenbiel, M., & Jucker, M. (2007) · Neurodegenerative Diseases · doi:10.1159/000101837 · Cited by 20

True and false discovery in DNA microarray experiments: Transcriptome changes in the hippocampus of presenilin 1 mutant mice

Unger, T. L., Korade, Ž., Lazarov, O., Terrano, D. T., Sisodia, S. S., & Mirnics, K. (2005) · Methods · doi:10.1016/j.ymeth.2005.09.005 · Cited by 20

Patient-Derived Fibroblasts With Presenilin-1 Mutations, That Model Aspects of Alzheimer’s Disease Pathology, Constitute a Potential Object for Early Diagnosis

López-Toledo, G., Silva‐Lucero, M., Herrera‐Díaz, J., García, D.-E., Arias‐Montaño, J., & Cárdenas‐Aguayo, M. D. C. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.921573 · Cited by 20

Amelioration of cognitive impairments in APPswe/PS1dE9 mice is associated with metabolites alteration induced by total salvianolic acid

Shen, L., Han, B., Geng, Y., Wang, J., Wang, Z., & Wang, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0174763 · Cited by 19

Animal Models of Psychosis in Alzheimer Disease

Krivinko, J. M., Koppel, J. L., Savonenko, A. V., & Sweet, R. A. (2019) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2019.05.009 · Cited by 19

Cellular prion protein modulates β-amyloid deposition in aged APP/PS1 transgenic mice

Ordóñez‐Gutiérrez, L., Torres, J. M., Gavı́n, R., Antón, M., Arroba, A. I., Espinosa, J. C., Vergara, C., del Rı́o, J. A., & Wandosell, F. G. (2013) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.05.019 · Cited by 19

Aβ Infusion and Related Models of Alzheimer Dementia

Lawlor, P. A., & Young, D. (2010) · Neuromethods · doi:10.1007/978-1-60761-898-0_17 · Cited by 19

Fimbria–Fornix Lesion Does Not Affect APP Levels and Amyloid Deposition in the Hippocampus of APP+PS1 Double Transgenic Mice

Liu, L., Ikonen, S., Tapiola, T., Tanila, H., & van Groen, T. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.8015 · Cited by 19

Animal Models of Dementia

Choi, D., & Lee, J. (2011) · Brain & Neurorehabilitation · doi:10.12786/bn.2011.4.1.21 · Cited by 19

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

Holcomb, L., Gordon, M. N., McGowan, E., Yu, X., Benkovic, S., Jantzen, P., Wright, K., Saad, I., Mueller, R., Morgan, D., et al. (1998) · Nature Medicine · doi:10.1038/nm0198-097 · Cited by 1,386

FAD mutant PS-1 gene-targeted mice: increased Aβ42 and Aβ deposition without APP overproduction

Flood, D. (2002) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00330-x · Cited by 131

Amyloid production and deposition in mutant amyloid precursor protein and presenilin-1 yeast artificial chromosome transgenic mice

Lamb, B. T., Bardel, K. A., Kulnane, L. S., Anderson, J. J., Holtz, G., Wagner, S. L., Sisodia, S. S., & Hoeger, E. J. (1999) · Nature Neuroscience · doi:10.1038/11154 · Cited by 102

Transgenic mice with Alzheimer presenilin 1 mutations show accelerated neurodegeneration without amyloid plaque formation

Chui, D.-H., Tanahashi, H., Ozawa, K., Ikeda, S., Checler, F., Ueda, O., Suzuki, H., Araki, W., Inoue, H., Shirotani, K., et al. (1999) · Nature Medicine · doi:10.1038/8438 · Cited by 364

Presenilin Proteins and the Pathogenesis of Early-Onset Familial Alzheimer’s Disease: β-Amyloid Production and Parallels to Prion Diseases

Westaway, D. A., Carlson, G. A., Bergeron, C., Lévesque, G., Sherrington, R., Yao, H., Strome, R., Perry, B. J., Davies, A., Gandy, S., et al. (1998) · Springer eBooks · doi:10.1007/978-1-4899-1896-3_17 · Cited by 1